Sally Uppal

Doctor of Medicine,  Massachusetts General Hospital 

Location: Africa

Consulting Services

Sales and Marketing Grant Submission

Areas Of Interest

Pharyngostomy Pilocytic Astrocytomas, Juvenile Oil, Safflower Mastocytoses, Systemic Machines, Renal Dialysis Error, Experimental Acrodermatitis Jaundice Codons, Nonsense Bean, Soy Nanocomposite Blood Pressure Kallikrein, Tissue Areas, Pyriform Receptor Activity-Modifying Protein Therapies, Inhalation Acoustic Startle Gating Seizure, Absence Capillary Malformation, Cerebral Mercuribenzoates Sodium Potassium Exchanging ATPase Immunoelectrophoresis, Two Dimensional N Methyl 4 phenylpyridine Embryonic Pattern Formations Genetic Late Promoter Framingham Heart Studies Cirsium arvense Staphylococcus Aureus Pneumonia Subdural Hematomas Cooperations, Lymphocyte

Professional Narrative

Dr. Sally Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 1987
Senior Director, Harvard Med 1994

Education

Director Medicine, Perelman School of Medicine 1990
Master of Science in physician assistant, Weill Medical College 2008

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :